Top Markets
Coin of the day
U-Neuron Biomedical Inc U-Neuron Biomedical Inc

U-Neuron Biomedical Inc

6973
Rank in Stocks #25638
U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell... U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell technologies. The company's core activities revolve around advancing methods for stem cell preservation, isolation, and their subsequent application in therapeutic treatments. Their research specifically targets Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. This enterprise was established on September 4, 2015, and is based in New Taipei, Taiwan.
Share Price
$1.24
Market Cap
$47.75M
Change (1 day)
-0.38%
Change (1 year)
2.76%
Country
TW
Trade U-Neuron Biomedical Inc (6973)

Category

Operating Margin for U-Neuron Biomedical Inc (6973)
Operating Margin as of 2026 TTM: 0.00%
According to U-Neuron Biomedical Inc latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for U-Neuron Biomedical Inc from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
-149.01% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.